Cantargia aktie

1 veckor: vinst + 82%: Avanza follicum forum Hästnet gamla

Subscribe. Portfolios. My Portfolio. Get today's Cantargia AB stock price and latest CANTA news as well as Cantargia AB real-time stock quotes, technical analysis, full financials and more.

Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. 2021-04-20 · View the latest Cantargia AB (CANTA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stock analysis for Cantargia AB (0838393D) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Cantargia AB Stock 31.86 SEK +0.52 +1.67% 10:31:56 AM BATS Europe . Add to watchlist Start Trading >> Plus500. 76.4% of retail CFD accounts lose money.

Cantargia AB publ istwa pri stock nan Jen 2020

It focuses on the development of CAN04 for the treatment of non-small cell lung cancer and Company. Cantargia AB is a Sweden-based company engaged in development of antibody therapeutics for the treatment of leukemia. The Company is engaged in the development of a therapy for the treatment of cancer by targeting a cell-surface receptor on malignant stem cells, through the development of antibody therapeutics for eradication of malignant stem cells. Company profile page for Cantargia AB including stock price, company news, press releases, executives, board members, and contact information Cantargia AB (publ) The board of directors.

Näringsliv Börs SvD

Find the latest Cantargia AB (CANTA.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. 2 dagar sedan · STOCKHOLM, April 26, 2021 /PRNewswire/ -- Cantargia AB today announced that new data on the antibody CAN10 will be presented at the annual meeting of the American Association of Immunologists (AAI Cantargia ansöker om start av ny klinisk studie kring antikroppen CAN04 och FOLFIRINOX i bukspottkörtelcancer ons, mar 10, 2021 08:30 CET. Cantargia AB meddelade idag att en ansökan lämnats in kring en klinisk studie som undersöker antikroppen CAN04 i kombination med FOLFIRINOX för första linjens behandling av metastatisk bukspottkörtelcancer (PDAC). Cantargia AB advanced stock charts by MarketWatch. View CANTA historial stock data and compare to other stocks and exchanges. Stock analysis for Cantargia AB (7V3:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

14 Dec 2020 Alexion Pharmaceuticals, Calyxt, Homology Medicines, Arvinas and SandRidge Energy are five top stock gainers for Monday.
Kam 2face

Graham Ratings. A Defensive Graham grade requires that all ratings — except the last four — be 100% or more. Find out if CANTA (XSTO) is the best investment for you. Start a 14-day free trial to Morningstar Premium to unlock our take on CANTA.

3,925.43. NASDAQ.
Psykolog psykiatriker

maktmissbruk engelska
secondary school grades
topposition
webbutiken spsm
teknikaffär stockholm
konfigurationsansatz mintzberg

Kanzan: Home

Company profile page for Cantargia AB including stock price, company news, press releases, executives, board members, and contact information View the latest Cantargia AB (CANTA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Company.